New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship
---
identifier: "/us/fr/C1-2016-07135"
source: "fr"
legal_status: "authoritative_unofficial"
title: "New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship"
title_number: 0
title_name: "Federal Register"
section_number: "C1-2016-07135"
section_name: "New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship"
positive_law: false
currency: "2016-04-01"
last_updated: "2016-04-01"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "C1-2016-07135"
document_type: "rule"
publication_date: "2016-04-01"
agencies:
- "Health and Human Services Department"
- "Food and Drug Administration"
cfr_references:
- "21 CFR Part 510"
- "21 CFR Part 520"
- "21 CFR Part 522"
- "21 CFR Part 524"
- "21 CFR Part 528"
- "21 CFR Part 529"
- "21 CFR Part 556"
- "21 CFR Part 558"
fr_citation: "81 FR 18749"
fr_volume: 81
docket_ids:
- "Docket No. FDA-2015-N-0002"
---
# [Corrected]
**Correction**
In rule document 2016-07135 beginning on page 17604 in the issue of Wednesday, March 30, 2016, make the following correction:
**21 CFR Part 524**
§ 524.1044g
On page 17608, change amendatory instruction 33 to read as follows:
33. In § 524.1044g, in paragraph (b)(3), remove “000859” and in its place add “069043”.